Amaç: İnfertilite kliniklerinde, inmemiş testis nedeni ile testis atrofisi gelişen olgu biopsilerinde testiste normalde olmayan mast hücreleri tespit edilmiştir. Buna bağlı olarak, testis atrofisine giden fibrozis sürecinde mast hücrelerinin katkısı olduğu düşünülmüştür. Çalışmamızda amaç, rat testis torsiyon- detorsiyon modelinde testiste gelişen fibrozisin önlemesi amacıyla bir mast hücre stabilizatörü olan ketotifenin etkinliğinin araştırılmasıdır.
Materyal- Metod: Otuz rat, üç eşit gruba ayrıldı. Grup A’ da testis yapıları gubernakulumdan ayrılıp torsiyon yapmadan yerine kondu (sham). Grup B’ de sağ testiküler torsiyon oluşturulup dört saat sonra detorsiyone edildi. Grup C’ de dört saatlik torsiyonu takiben detorsiyon yapılan ratlara ketotifen (1 mg/kg/gün, oral yolla, birinci günden itibaren üç haftaya kadar verildi). Ratlar, üç hafta sonra anestezi altında sakrifiye edilerek testiküler fibrozis gelişimi yönünden değerlendirildi. Histopatolojik değerlendirme Johnsen skoru kullanılarak yapıldı.
Sonuçlar: Johnsen scorlarının median değerleri grup A, B, C’ de sırasıyla 9,9, 3,7 ve 8,4 bulundu. Grup C (ketotifen) diğer gruplar ile karşılaştırıldığında, Johnsen skoru yüksekliği istatistiksel olarak anlamlı bulundu (p< 0.05) (Kruskall-Wallis). İkili karşılaştırma yapıldığında gruplar arasında anlamlı farklar olduğu saptandı: grup A-B; p=0,0001, grup B-C; p=0,039, grup A-C; p=0,006).
Tartışma: Bir testis torsiyon-detorsiyon rat modelinde, ketotifenin bir mast hücre stabilizatörü olarak testis fibrozisine karşı önleyici etkinliği olduğunu saptadık. Torsiyon- detorsiyon sonrasında kalan testiste mast hücre ekspresyonu ve germ hücre aktivitesini ilişkilendiren klinik çalışmalar yol gösterici olacaktır.
Testis torsiyonu testiste fibrozis mast hücre stabilizatörü ketotifen
Ankara Çocuk Sağlığı ve Hastalıkları Hematoloji Onkoloji Eğitim Araştırma Hastanesi Eğitim Fonu
Background: In infertility clinics, biopsies taken from undescended atrophic testicles showed increased mast cells which are not found in normal testis. So, it was thought that mast cells could have a contributing effect on fibrosis leading to testicular atrophy. Our aim of the study is to investigate the efficacy of ketotifen, which is a mast cell stabilizer, on the prevention of testicular fibrosis in a testicular torsion-detorsion rat model.
Materials and Methods: Thirty rats were divided into three equal groups, each consisting of ten animals. In group A; the testicular tissues were only separated from the gubernaculum without torsion (Sham). In group B, detorsion was performed after four hours of testicular torsion in the right testes. In group C, after four hours of right testicular torsion and detorsion, the rats were taken ketotifen as a medical treatment (1 mg/kg/day, orally started on the first day, continued for three weeks). The rats were sacrificed under anesthesia, three weeks after surgery to determine testicular fibrosis. Histopathologic evaluation was performed with Johnsen's score in both testes as a control evaluation.
Results: According to Johnsen score, median values were found 9.9 in group A; 3.7 in group B, and 8.4 in group C. Johnsen score was found significantly high in group C (with ketotifen) when compared with the other groups (p< 0.05). When we made a pairwise comparison, we found a significant difference between the group's A and B (p=0.0001), the group’s B and C; (p=0.039), and the group’s A and C (p=0.006).
Conclusion: We found that ketotifen had a preventing effect against testicular fibrosis as a mast cell stabilizer in the testis torsion-detorsion rat model.
Ketotifen Mast cell stabilizer Testis torsion Testicular fibrosis
Birincil Dil | İngilizce |
---|---|
Konular | Cerrahi |
Bölüm | ORIGINAL ARTICLES |
Yazarlar | |
Yayımlanma Tarihi | 25 Mayıs 2021 |
Gönderilme Tarihi | 14 Nisan 2021 |
Yayımlandığı Sayı | Yıl 2021 Cilt: 15 Sayı: 3 |
The publication language of Turkish Journal of Pediatric Disease is English.
Manuscripts submitted to the Turkish Journal of Pediatric Disease will go through a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in the field, in order to ensure an unbiased evaluation process. The editorial board will invite an external and independent editor to manage the evaluation processes of manuscripts submitted by editors or by the editorial board members of the journal. The Editor in Chief is the final authority in the decision-making process for all submissions. Articles accepted for publication in the Turkish Journal of Pediatrics are put in the order of publication, with at least 10 original articles in each issue, taking into account the acceptance dates. If the articles sent to the reviewers for evaluation are assessed as a senior for publication by the reviewers, the section editor and the editor considering all aspects (originality, high scientific quality and citation potential), it receives publication priority in addition to the articles assigned for the next issue.
The aim of the Turkish Journal of Pediatrics is to publish high-quality original research articles that will contribute to the international literature in the field of general pediatric health and diseases and its sub-branches. It also publishes editorial opinions, letters to the editor, reviews, case reports, book reviews, comments on previously published articles, meeting and conference proceedings, announcements, and biography. In addition to the field of child health and diseases, the journal also includes articles prepared in fields such as surgery, dentistry, public health, nutrition and dietetics, social services, human genetics, basic sciences, psychology, psychiatry, educational sciences, sociology and nursing, provided that they are related to this field. can be published.